Compare · LEXX vs TLRY
LEXX vs TLRY
Side-by-side comparison of Lexaria Bioscience Corp. (LEXX) and Tilray Brands Inc. (TLRY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both companies sit in the Health Care sector. LEXX focuses on Biotechnology: Pharmaceutical Preparations, while TLRY focuses on Medicinal Chemicals and Botanical Products.
- TLRY is the larger of the two at $368.0M, about 41.8x LEXX ($8.8M).
- TLRY has been more active in the news (7 items in the past 4 weeks vs 3 for LEXX).
- TLRY has more recent analyst coverage (14 ratings vs 0 for LEXX).
- Company
- Lexaria Bioscience Corp.
- Tilray Brands Inc.
- Price
- -
- -
- Market cap
- $8.8M
- $368.0M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Biotechnology: Pharmaceutical Preparations
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2018
- News (4w)
- 3
- 7
- Recent ratings
- 0
- 14
Lexaria Bioscience Corp.
Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. The company has licensed DehydraTECH to various companies operating in the nicotine, pharmaceutical, nutraceutical, and vitamin industries. Lexaria Bioscience Corp. was founded in 2004 and is headquartered in Kelowna, Canada.
Tilray Brands Inc.
Tilray, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. The company operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. It provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products. The company offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company was formerly known as Aphria Inc. Tilray, Inc. was incorporated in 2018 and is based in New York, New York.
Latest LEXX
- Lexaria Enters a New Pharmaceutical Agreement for DehydraTECH
- Lexaria Celebrates its 70th Patent Award
- Lexaria's Human Study GLP-1-H26-7 Reaches Full Enrollment and Continues Dosing on Schedule
- Lexaria Announces Results from Animal Study GLP-1-A26-1
- SEC Form EFFECT filed by Lexaria Bioscience Corp.
- SEC Form 424B3 filed by Lexaria Bioscience Corp.
- GLP-1 Weight-Loss/Diabetes Industries Continue Transition to Oral Medications
- SEC Form S-3 filed by Lexaria Bioscience Corp.
- Lexaria Updates Financial Position
- Lexaria Announces Closing of Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds
Latest TLRY
- 10 Barrel Brewing, Widmer Brothers and Hop Valley Named Official Craft Beer Partners of the Portland Trail Blazers
- Whiskey You Won't Find on Shelves: Breckenridge Distillery Launches the 2 Mile High Whiskey Club
- Tilray Brands Announces Strategy to Strengthen Canadian Cannabis Operations and Drive Profitable Growth
- Breckenridge Distillery and University of Denver Athletics Release Limited-Edition Whiskey Celebrating Record 11th NCAA Men’s Hockey Championship
- Tilray Brands Announces Next Phase of Beverage Transformation
- Blue Point Brewing Co.’s Legendary Cask Ales Festival Returns to Patchogue with 100+ Limited-Release Brews
- West Ham United F.C. and BrewDog Unveil Boleyn Brew: A Fan-Created Matchday Beer Made by Hammers, for Hammers
- SweetWater Brewing Gives Fans the Chance to Win Tickets to Their Dream Show at AEG Venues Across Georgia
- Tilray Medical Strengthens Global Medical Cannabis Supply Chain with Approval to Bring Critical EU-GMP Quality Testing In-House, Accelerating Product Release Across Regulated Global Markets
- SEC Form 10-Q filed by Tilray Brands Inc.